Bank of America Corp DE Invests $61.16 Million in Teleflex Incorporated $TFX

Key Points

• Bank of America bought 482,457 Teleflex shares worth approximately $61.2 million in the second quarter, giving it a 1.14% stake. Institutional investors and hedge funds collectively own 95.62% of the company.
• Teleflex exceeded quarterly expectations, reporting $1.76 in EPS and $570.33 million in revenue, with revenue up 28.9% year over year. The company issued full-year 2026 EPS guidance of $6.90–$7.20.
• Analysts maintain a generally cautious outlook, with the stock carrying an overall “Hold” rating and an average price target of $152.90, while Teleflex continues paying a quarterly dividend of $0.34 per share.

Bank of America Corp DE purchased a new position in Teleflex Incorporated (NYSE:TFX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 482,457 shares of the medical technology company's stock, valued at approximately $61,156,000. Bank of America Corp DE owned about 1.14% of Teleflex at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Teleflex in the 2nd quarter valued at about $688,537,000. Jupiter Topco LLC acquired a new position in Teleflex in the second quarter worth about $550,456,000. Janus Henderson Group PLC grew its stake in Teleflex by 1.1% in the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company's stock worth $513,281,000 after purchasing an additional 45,199 shares in the last quarter. Geode Capital Management LLC increased its holdings in Teleflex by 10.6% in the fourth quarter. Geode Capital Management LLC now owns 985,684 shares of the medical technology company's stock valued at $120,312,000 after buying an additional 94,679 shares during the last quarter. Finally, Irenic Capital Management LP acquired a new stake in Teleflex during the first quarter valued at approximately $104,061,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Mizuho lifted their target price on Teleflex from $140.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 15th. Truist Financial upped their price target on Teleflex from $143.00 to $150.00 and gave the company a "hold" rating in a research report on Monday, August 10th. UBS Group raised their price objective on Teleflex from $145.00 to $158.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 11th. Needham & Company LLC lifted their price objective on shares of Teleflex from $159.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, August 25th. Finally, Wall Street Zen raised shares of Teleflex from a "sell" rating to a "hold" rating in a report on Sunday, August 9th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $152.90.

Teleflex Stock Performance

Shares of TFX opened at $124.49 on Monday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The firm has a fifty day moving average of $135.10 and a 200-day moving average of $128.45. The company has a market cap of $5.27 billion, a price-to-earnings ratio of -5.35, a price-to-earnings-growth ratio of 0.83 and a beta of 0.82. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $145.00.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The business's revenue for the quarter was up 28.9% compared to the same quarter last year. During the same period in the prior year, the company posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, August 14th. Teleflex's payout ratio is currently -5.84%.

Teleflex Company Profile

Teleflex Incorporated is a global medical technology company that develops, manufactures and supplies specialty medical devices for hospitals, clinicians and other health care providers. Its products are designed to support procedures in areas including vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgery and urology.

The company's portfolio includes Arrow branded vascular access and catheter products, airway management devices, regional anesthesia products, surgical instruments, interventional devices and urological products.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.